Clinical guidelines & publications library
-
ECT treatment during the COVID-19 pandemic
Electroconvulsive therapy & neurostimulation
Considerations and precautions for the delivery of ECT during the pandemic. PDF Clinical guideline
Clinical guideline- Last updated: Aug 2022
- Published in Australia
-
rTMS therapy during the COVID-19 pandemic
COVID-19, Electroconvulsive therapy & neurostimulation
PDF Clinical guideline
Clinical guideline- Last updated: Aug 2022
- Published in Australia
-
Deep brain stimulation
Electroconvulsive therapy & neurostimulation
A clinical memorandum to inform psychiatrists who are interested in using Deep Brain Stimulation (DBS) as a treatment for psychiatric disorders. PDF Clinical guideline
Clinical guideline- Last updated: Jul 2022
- Published in Australia
-
Antipsychotic medications as a treatment of behavioural and psychological symptoms of dementia
Dementia
This guideline has been rescinded pending review. PDF Clinical guideline
Clinical guideline- Last updated: Aug 2016
- Published in Australia
- PPG #10
- Rescinded
-
Australian Family Court proceedings
Forensic, Medico-legal
Guidance to members about family court proceedings including custody issues, being an expert witness, testifying and reports. PDF Clinical guideline
Clinical guideline- Last updated: Feb 2019
- Published in Australia
- PPG #3
-
Psychiatrists, general practitioners and psychologists
GPs and psychiatrists
Best practice referral, communication and shared care arrangements between psychiatrists, general practitioners and psychologists PDF Clinical guideline
Clinical guideline- Last updated: Apr 2014
- Published in Australia
-
Treating hepatitis C
Hepatitis C
Guidance for psychiatrists to facilitate care for people living with mental illness who are living with, or at risk of contracting hepatitis C. PDF Clinical guideline
Clinical guideline- Last updated: Nov 2022
- Published in Australia
- PPG #21
-
Illicit drugs policy
Illicit drugs
This joint statement from RACP and RANZCP is for individuals and organisations in Australia and New Zealand involved in the development of policies and programs concerned with illicit drug problems. PDF Clinical guideline
Clinical guideline- Last updated: Feb 2006
- Published in Australia
-
Use of ketamine in psychiatric practice
Ketamine
Information for psychiatrists about the potential utility of ketamine in psychiatric practice. PDF Clinical guideline
Clinical guideline- Last updated: Jul 2022
- Published in Australia
-
Medical benefits for psychiatric treatment and training
Medicare
This document is under review. PDF Clinical guideline
Clinical guideline- Last updated: Nov 1991
- Published in Australia
- PPG #1
- Under review
-
Access and use of clinical information for medico-legal report writers in New Zealand
Medico-legal
This guideline provides specific advice on managing the privacy implications when accessing and using privileged health information in the New Zealand medico-legal setting. PDF Clinical guideline
Clinical guideline- Last updated: Aug 2021
- Published in New Zealand
- PPG #17
-
Reports and medical examinations in medico-legal settings
Medico-legal
Developing reports and conducting independent medical examinations in medico-legal settings. PDF Clinical guideline
Clinical guideline- Last updated: Nov 2020
- Published in Australia
- PPG #11
-
National codes and standards relevant to psychiatry practice and mental health services in Australia and New Zealand
Health service standards
A resource for RANZCP members to readily identify and access national codes and standards relevant to psychiatry practice. PDF Clinical guideline
Clinical guideline- Last updated: Apr 2017
- Published in Australia
- PPG #14
-
Off-label prescribing in psychiatry
Off-label prescribing
The Royal Australian New Zealand College of Psychiatrists (RANZCP) has developed this
guidance to provide advice to psychiatrists who may be considering the use of medications ‘off label’, with a key focus on risk identification and justification. PDF Clinical guidelineClinical guideline- Last updated: Dec 2023
- Published in Australia
- PPG #4
-
Administration of repetitive transcranial magnetic stimulation (rTMS)
Electroconvulsive therapy & neurostimulation
Guidance on key professional practice issues that psychiatrists should consider when prescribing and administering repetitive transcranial magnetic stimulation (rTMS). PDF Clinical guideline
Clinical guideline- Last updated: Nov 2018
- Published in Australia
- PPG #16
-
Guidance for the use of stimulant medications in adults
Stimulant medications
The RANZCP supports the appropriate use of these drugs in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy in adults. PDF Clinical guideline
Clinical guideline- Last updated: Oct 2015
- Published in Australia
- PPG #6
-
Tobacco policy
Addiction, Smoking cessation
Solutions for tobacco control to change the way physicians and psychiatrists view their role in reducing mortality and morbidity due to tobacco smoking. PDF Clinical guideline
Clinical guideline- Last updated: Jun 2005
- Published in Australia
-
Transcranial Direct Current Stimulation (tDCS)
Electroconvulsive therapy & neurostimulation
This memorandum is for psychiatrists who are interested in using transcranial direct current stimulation (tDCS) as a treatment for psychiatric disorders. PDF Clinical guideline
Clinical guideline- Last updated: Jul 2022
- Published in Australia
-
rTMS in hospitals
Electroconvulsive therapy & neurostimulation
Guidance on the delivery of Medicare-funded repetitive transcranial magnetic stimulation (rTMS) services in hospitals PDF Clinical guideline
Clinical guideline- Last updated: Nov 2021
- Published in Australia
-
Implementing alternatives to coercion
Seclusion and restraint
The RANZCP has endorsed this position produced by the World Psychiatric Association. URL Clinical guideline
Clinical guideline- Last updated: Oct 2020
- Published in International
- Endorsed external guidance